visual 1

The BioMed Alliance released a new statement and a letter to Commission President Ursula von der Leyen calling for support for medical and research societies to ensure continued guidance for healthcare professionals during the COVID-19 Pandemic.

The COVID-19 pandemic poses a major challenge that has a disruptive effect on European health systems and societies. European health professionals are working around the clock to save the lives of European patients, and governments and the EU Institutions are doing everything in their power to support their heroic efforts. However, the medical and research societies that health professionals rely on for up-to-date information on clinical practice are facing serious challenges. As medical congresses are being cancelled or postponed, not-for-profit societies are faced with substantial costs that may threaten their existence and thus their ability to provide clinical guidance to health professionals. Therefore, the Biomedical Alliance in Europe calls on the EU and Member States to support medical societies to ensure they can continue providing their services now and in the future.

Read the letter to President Ursula von der Leyen here and the statement here

Take a look at our February Update to find more information about our activities in this month.

EU Health Coalition

The EU Health Coalition, in which the BioMed Alliance is an active member and chairs the research & innovation policy group, announced that the next EU Health Summit takes place on 4-5 May 2020. The high-level summit will be held in the Flemish Parliament and we look forward to organising the programme together with our partners. The conference will focus on the implementation of an updated version of the recommendations that were presented during the last conference in the end of 2018.

More information and the registration form are available here: https://www.euhealthcoalition.eu/event/eu-health-summit-2020/ 

Read the first Update of the new decade here to see how we started the year and to get a glimpse of what lies ahead.

IMG 4047

The BioMed Alliance started 2020 well, with a new President, President-Elect and a new Board Member. We look forward to working with them on the many interesting activities that we are planning this year.

  • In January, we welcomed our new President, Prof. Wilfried Ellmeier from the Medical University of Vienna. He has prepared for this role over the past two years as President-Elect and has extensive experience within the BioMed Alliance.
  • This means that Prof. Axel Pries has stepped down as president and will continue to be active as Past-President. We can all agree that Prof. Pries has been a great president that was very committed to the BioMed Alliance. Under his leadership, the organisation has developed substantially.
  • Prof. Gunhild Waldemar was appointed as President-Elect, her candidacy was approved during the General Assembly last November. Prof. Tobias Welte has taken over her role as treasurer.
  • We will also welcome a new Board Member, Prof. Tom Hemming Karlsen took over the seat of Prof. Colm O’Morain, who has come to the end of his term in the Board and has played an important role in the BioMed Alliance as Board Member, President-Elect, President and Past-President.

For more information about our Board Members, take a look at our Board of Directors Page.

activities 1

The BioMed Alliance and FEAM joined forces to co-organise a workshop exploring opportunities and challenges for maximising the impact of health research in the coming years. The event: ‘Working together for the Future of European Health Research’ takes place on 31 January from 11.00-13.00 in the European Parliament. The two-hour workshop includes presentations from leading academics, stakeholder representatives, MEPs, and key policy makers in the European Commission. The event is hosted by MEP Cristian Bușoi (EPP), MEP Graça Carvalho (EPP) and MEP Petra De Sutter (Greens/EFA).

With the increasing disease burden and challenges faced by European healthcare systems, health research is more important than ever. It has a transformative impact on the lives of patients and provides return on investment to society. Nonetheless, bottlenecks persist, including fragmentations in the health research funding system and limitations to the sustainability of funding. Health research is constantly evolving, and policy makers and researchers should work together to ensure that researchers have access to new developments, concepts and technologies needed to develop innovative ideas. At the same time, efforts should focus on effectively scaling-up and implementing these innovations, so they quickly reach patients. Cross-sectoral and cross-border cooperation are key in ensuring health research meets societal needs. Therefore, FEAM and the BioMed Alliance partner with influential policy makers and experienced researchers to have an open discussion on the future of European health research.

For more information, the agenda is available here and the registration form can be found here.

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.